Lista de obras - Leif Friberg - Dominio Público Uruguay

A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke

artículo científico publicado en 2014

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records.

artículo científico publicado en 2017

Adherence to warfarin treatment among patients with atrial fibrillation

artículo científico publicado en 2014

Alcohol-related hospitalization is associated with increased risk of ischaemic stroke among low-risk patients with atrial fibrillation.

artículo científico publicado en 2017

Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention

artículo científico publicado en 2017

Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study

artículo científico publicado en 2012

Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction.

artículo científico publicado en 2001

Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction

artículo científico publicado en 2014

Atrial fibrillation more common than previously thought. Stroke prophylaxis needs to be improved

artículo científico publicado en 2013

Atrial fibrillation patients do not benefit from acetylsalicylic acid

artículo científico publicado en 2013

Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.

artículo científico publicado en 2016

Atrial fibrillation prevalence revisited.

artículo científico publicado en 2013

Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study

scientific article published on 27 August 2013

Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study

artículo científico publicado en 2014

Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.

artículo científico publicado en 2015

Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: report from the Stockholm Cohort Study of Atrial Fibrillation ⬇️

artículo científico publicado el 4 de febrero de 2011

Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.

artículo científico publicado en 2016

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

artículo científico publicado en 2011

Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).

artículo científico publicado en 2009

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation

artículo científico publicado en 2017

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

artículo científico publicado en 2012

Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.

artículo científico publicado en 2016

Growth hormone and insulin-like growth factor-1 in acute myocardial infarction

artículo científico publicado en 2000

Heart failure: a weak link in CHA2 DS2 -VASc.

artículo científico publicado en 2018

High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report

artículo científico publicado en 2017

High prevalence of atrial fibrillation among patients with ischemic stroke.

artículo científico publicado en 2014

Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF).

artículo científico publicado en 2007

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation

scientific article published on 01 July 2019

Less dementia with oral anticoagulation in atrial fibrillation.

artículo científico publicado en 2017

Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study

artículo científico

N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.

artículo científico

Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study

artículo científico publicado en 2012

Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP) ⬇️

artículo científico publicado el 11 de julio de 2012

RISK OF STROKE IN WOMEN AND MEN WITH ATRIAL FIBRILLATION AND ONLY ONE ADDITIONAL CHA2DS2-VASC RISK FACTOR

Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure

artículo científico publicado en 2018

Registry-based studies of atrial fibrillation from Sweden and Denmark, 2000-2014.

artículo científico publicado en 2016

Reply to Dr Taya Glotzer's editorial about the Stroke Stop study (Europace 2013;15:5-6) ⬇️

artículo científico publicado el 1 de abril de 2013

Response to letter regarding article, "High prevalence of atrial fibrillation among patients with ischemic stroke".

artículo científico publicado en 2014

Risk of ischemic stroke and utility of CHA2 DS2 -VASc score in women and men with atrial fibrillation

artículo científico publicado en 2019

Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation.

artículo científico publicado en 2016

Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula

artículo científico publicado en 2015

Safety of dronedarone in routine clinical care

artículo científico publicado en 2014

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration

artículo científico publicado en 2017

Short lookback periods causing exaggerated stroke risk estimates in atrial fibrillation may expose patients to unnecessary anticoagulant treatment

artículo científico publicado en 2019

Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.

artículo científico publicado en 2016

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation

artículo científico publicado en 2009

Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).

artículo científico publicado en 2006

The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: report from the Stockholm Cohort of Atrial Fibrillation (SCAF)

artículo científico publicado en 2009

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.

artículo científico publicado en 2017

Use of oral anticoagulants after ischaemic stroke in patients with atrial fibrillation and cancer

scientific article published on 09 May 2020

Usefulness of Health Registers for detection of bleeding events in outcome studies

artículo científico publicado en 2016

[Anticoagulants to more people can prevent many cases of stroke]

artículo científico publicado en 2015

Lista de obras de Leif Friberg

A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records.

Adherence to warfarin treatment among patients with atrial fibrillation

Alcohol-related hospitalization is associated with increased risk of ischaemic stroke among low-risk patients with atrial fibrillation.

Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention

Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study

Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction.

Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction

Atrial fibrillation more common than previously thought. Stroke prophylaxis needs to be improved

Atrial fibrillation patients do not benefit from acetylsalicylic acid

Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.

Atrial fibrillation prevalence revisited.

Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study

Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study

Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.

Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: report from the Stockholm Cohort Study of Atrial Fibrillation ⬇️

Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.

Growth hormone and insulin-like growth factor-1 in acute myocardial infarction

Heart failure: a weak link in CHA2 DS2 -VASc.

High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report

High prevalence of atrial fibrillation among patients with ischemic stroke.

Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF).

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation

Less dementia with oral anticoagulation in atrial fibrillation.

Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study

N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.

Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study

Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP) ⬇️

RISK OF STROKE IN WOMEN AND MEN WITH ATRIAL FIBRILLATION AND ONLY ONE ADDITIONAL CHA2DS2-VASC RISK FACTOR

Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure

Registry-based studies of atrial fibrillation from Sweden and Denmark, 2000-2014.

Reply to Dr Taya Glotzer's editorial about the Stroke Stop study (Europace 2013;15:5-6) ⬇️

Response to letter regarding article, "High prevalence of atrial fibrillation among patients with ischemic stroke".

Risk of ischemic stroke and utility of CHA2 DS2 -VASc score in women and men with atrial fibrillation

Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation.

Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula

Safety of dronedarone in routine clinical care

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration

Short lookback periods causing exaggerated stroke risk estimates in atrial fibrillation may expose patients to unnecessary anticoagulant treatment

Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation

Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).

The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: report from the Stockholm Cohort of Atrial Fibrillation (SCAF)

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.

Use of oral anticoagulants after ischaemic stroke in patients with atrial fibrillation and cancer

Usefulness of Health Registers for detection of bleeding events in outcome studies

[Anticoagulants to more people can prevent many cases of stroke]